Caterwealth Pharmaceutical And Healthcare Industry Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 22-06-2024
- Paid Up Capital ₹ 0.20 M
as on 22-06-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Caterwealth Pharmaceutical And Healthcare Industry
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Atluri and Ravindra Atluri serve as directors at the Company.
- CIN/LLPIN
U51909TG2021PTC152751
- Company No.
152751
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Caterwealth Pharmaceutical And Healthcare Industry?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Suresh Atluri | Director | 02-Jul-2021 | Current |
Ravindra Atluri | Director | 02-Jul-2021 | Current |
Financial Performance of Caterwealth Pharmaceutical And Healthcare Industry.
Enhance accessibility to Caterwealth Pharmaceutical And Healthcare Industry's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Caterwealth Pharmaceutical And Healthcare Industry?
Unlock access to Caterwealth Pharmaceutical And Healthcare Industry's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Caterwealth Management And Consultancy LlpActive 2 years 4 months
Suresh Atluri and Ravindra Atluri are mutual person
- Caterwealth Technologies LlpActive 2 years 3 months
Suresh Atluri and Ravindra Atluri are mutual person
- Caterwealth Realestate LlpActive 2 years 3 months
Suresh Atluri and Ravindra Atluri are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Caterwealth Pharmaceutical And Healthcare Industry?
Caterwealth Pharmaceutical And Healthcare Industry has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caterwealth Pharmaceutical And Healthcare Industry, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caterwealth Pharmaceutical And Healthcare Industry's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.